Mirum Pharmaceuticals, Inc. today announced the appointment of Doug Sheehy, JD, as chief legal officer. Mr. Sheehy was most recently chief legal officer and secretary at Sonoma Biotherapeutics, Inc., ...

Investing.com — 周一，H.C. Wainwright开始对Mirum制药 (NASDAQ: MIRM )进行覆盖，给予该公司股票"买入"评级，目标价为73.00美元。这与华尔街的普遍观点一致， InvestingPro 数据显示分析师目标价在53美元至79美元之间，形成强烈买入共识。该公司分析师强调，Mirum的有效商业策略和监管批准是推动公司在2025年及以后增长前景的关键因素。

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a biopharmaceutical company focused on the identification, acquisition, ...